850554-39-1

Basic information

• Product Name: Lithium, [1-(4-bromobenzoyl)-3-ethoxy-1-methyl-2,3-dioxopropyl]-
• CAS NO: 850554-39-1
• Molecular Formula: C13H12BrLiO4
• Molecular Weight: 319.081
• Mol File: 850554-39-1.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: Lithium, [1-(4-bromobenzoyl)-3-ethoxy-1-methyl-2,3-dioxopropyl]-(CAS DataBase Reference)
• NIST Chemistry Reference: Lithium, [1-(4-bromobenzoyl)-3-ethoxy-1-methyl-2,3-dioxopropyl]-(850554-39-1)
• EPA Substance Registry System: Lithium, [1-(4-bromobenzoyl)-3-ethoxy-1-methyl-2,3-dioxopropyl]-(850554-39-1)

Safety Data

• Hazardous Substances Data: 850554-39-1(Hazardous Substances Data)

Upstream product

• 95-92-1 oxalic acid diethyl ester 
• 10342-83-3 4'-Bromopropiophenone 

Downstream Products

• 183232-66-8 1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-methyl-N-(1-piperidinyl)-1H-pyrazole-3-carboxamide 
• 183232-62-4 5-(4-bromophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxylic acid ethyl ester 

Relevant articles and documents

Preparation of iodine-123 labeled AM251: A potential spect radioligand for the brain cannabinoid CB1 receptor

We report the synthesis and labeling with iodine-123 of N-(piperidin-1-yl)-5-(4-iodophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole -3-carboxamide (AM251). This compound is an anlog of the recently described cannabinoid receptor antagonist, R141716A,

Structure-activity relationships of pyrazole derivatives as cannabinoid receptor antagonists

As a potent, specific antagonist for the brain cannabinoid receptor (CB1), the biarylpyrazole N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4- dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716A; 1) was the lead compound for initiating studies desi